The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez, O. M.
Right arrow Articles by Aronson, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez, O. M.
Right arrow Articles by Aronson, F. R.

The Journal of Immunology, Vol 144, Issue 6 2211-2215, Copyright © 1990 by American Association of Immunologists


ARTICLES

IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells

OM Martinez, RS Gibbons, MR Garovoy and FR Aronson
Cytokine Biology Laboratory, University of California, San Francisco 94143-0128.

Recent studies have shown that IL-4 can affect lymphocyte responses to IL-2. To evaluate the effects of IL-4 on T cell responses to physiologically relevant stimuli, we studied normal human T cells cultured with a low concentration of anti-CD3 mAb and IL-2 in the presence and absence of added IL-4. The addition of IL-4 to cultures of T cells stimulated with anti-CD3 mAb and IL-2 reduced the proliferative response by 49 to 59%. The inhibitory effect was observed in 3-, 5-, and 7-day cultures. Inhibition was dose-dependent with maximal inhibition at concentrations greater than or equal to 5 to 10 U/ml IL- 4. IL-4-mediated inhibition occurred early during the T cell response, inasmuch as addition of IL-4 after stimulation for 24 h did not result in significant inhibition. Phenotypic analyses of cells cultured in the presence of anti-CD3 mAb, IL-2, and IL-4 suggested that the mechanism of regulation by IL-4 involves the inhibition of IL-2R expression. The proportion of both CD4+ and CD8+ cells that expressed IL-2R in response to IL-2 was diminished in the presence of IL-4, although HLA-DR levels were unaffected. Soluble IL-2R was also reduced in supernatants of cultures stimulated with anti-CD3 mAb, IL-2, and IL-4 as compared to cultures stimulated with anti-CD3 mAb and IL-2. These findings indicate that when normal human T cells are stimulated in vitro in a manner that approximates a physiologic interaction with Ag in vivo, rIL-4 provides a potent inhibitory signal to IL-2 responsive cells that is likely mediated by IL-4-induced inhibition of IL-2R expression.


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Olver, P. Groves, K. Buttigieg, E. S. Morris, M. L. Janas, A. Kelso, and N. Kienzle
Tumor-Derived Interleukin-4 Reduces Tumor Clearance and Deviates the Cytokine and Granzyme Profile of Tumor-Induced CD8+ T Cells
Cancer Res., January 1, 2006; 66(1): 571 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Conticello, F. Pedini, A. Zeuner, M. Patti, M. Zerilli, G. Stassi, A. Messina, C. Peschle, and R. De Maria
IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins
J. Immunol., May 1, 2004; 172(9): 5467 - 5477.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Zhang, T. Bardos, Q. Shao, J. Tschopp, K. Mikecz, T. T. Glant, and A. Finnegan
IL-4 Potentiates Activated T Cell Apoptosis Via an IL-2-Dependent Mechanism
J. Immunol., April 1, 2003; 170(7): 3495 - 3503.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Y. Yang, L. H. Wang, K. Mihalic, W. Xiao, T. Chen, P. Li, L. M. Wahl, and W. L. Farrar
Interleukin (IL)-4 Indirectly Suppresses IL-2 Production by Human T Lymphocytes via Peroxisome Proliferator-activated Receptor gamma Activated by Macrophage-derived 12/15-Lipoxygenase Ligands
J. Biol. Chem., February 1, 2002; 277(6): 3973 - 3978.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-R. Yu, R. A. Kirken, M. G. Malabarba, H. A. Young, and J. R. Ortaldo
Differential Regulation of the Janus Kinase-STAT Pathway and Biologic Function of IL-13 in Primary Human NK and T Cells: A Comparative Study with IL-4
J. Immunol., July 1, 1998; 161(1): 218 - 227.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J C Crispin and J Alcocer-Varela
Interleukin-2 and systemic lupus erythematosus--fifteen years later
Lupus, May 1, 1998; 7(4): 214 - 222.
[Abstract] [PDF]


Home page
ScienceHome page
G Lombardi, S Sidhu, R Batchelor, and R Lechler
Anergic T cells as suppressor cells in vitro
Science, June 10, 1994; 264(5165): 1587 - 1589.
[Abstract] [PDF]


Home page
ScienceHome page
M Kondo, T Takeshita, N Ishii, M Nakamura, S Watanabe, K Arai, and K Sugamura
Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4
Science, December 17, 1993; 262(5141): 1874 - 1877.
[Abstract] [PDF]


Home page
ScienceHome page
P Salgame, J. Abrams, C Clayberger, H Goldstein, J Convit, R. Modlin, and B. Bloom
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones
Science, October 11, 1991; 254(5029): 279 - 282.
[Abstract] [PDF]


Home page
ScienceHome page
D. Eardley and M. Koshland
Glycosylphosphatidylinositol: a candidate system for interleukin-2 signal transduction
Science, January 4, 1991; 251(4989): 78 - 81.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. Masuda, T. Matsuguchi, K. Yamaki, T. Hayakawa, M. Kubo, W. J. LaRochelle, and Y. Yoshikai
Interleukin-15 Induces Rapid Tyrosine Phosphorylation of STAT6 and the Expression of Interleukin-4 in Mouse Mast Cells
J. Biol. Chem., September 15, 2000; 275(38): 29331 - 29337.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.